Stress Management and Multiple Sclerosis: A Randomized Controlled Trial

Author： Artemiadis Artemios K.   Vervainioti Angeliki A.   Alexopoulos Evangelos C.   Rombos Antonis   Anagnostouli Maria C.   Darviri Christina  

Publisher： Oxford University Press

ISSN： 0887-6177

Source： Archives of Clinical Neuropsychology, Vol.27, Iss.4, 2012-06, pp. : 406-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

By Vollmer T.   Sorensen P.   Selmaj K.   Zipp F.   Havrdova E.   Cohen J.   Sasson N.   Gilgun-Sherki Y.   Arnold D.  

Journal of Neurology, Vol. 261, Iss. 4, 2014-04 ,pp. : 773-783

Springer Publishing Company

Access to resources Recommend Favorite

Effects of adjunct glucosamine sulfate on relapsing–remitting multiple sclerosis progression: Preliminary findings of a randomized, placebo-controlled trial

By Shaygannejad Vahid   Janghorbani Mohsen   Savoj Mohammad Reza   Ashtari Fereshteh  

Neurological Research, Vol. 32, Iss. 9, 2010-11 ,pp. : 981-985

Maney Publishing

Access to resources Recommend Favorite

A randomized controlled trial comparing an adult education class using cognitive behavioural therapy (“stress control”), anxiety management group treatment and a waiting list for anxiety disorders

By Kitchiner Neil   Edwards Deborah   Wood Steve   Sainsbury Sheila   Hewin Peter   Burnard Phillip   Bisson Jonathan  

Journal of Mental Health, Vol. 18, Iss. 4, 2009-08 ,pp. : 307-315

Informa Healthcare

Access to resources Recommend Favorite

Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

By Freedman Mark   Stefano Nicola   Barkhof Frederik   Polman Chris   Comi Giancarlo   Uitdehaag Bernard   Casset-Semanaz Florence   Hennessy Brian   Lehr Lorenz   Stubinski Bettina   Jack Dominic   Kappos Ludwig  

Journal of Neurology, Vol. 261, Iss. 3, 2014-03 ,pp. : 490-499

Springer Publishing Company

Access to resources Recommend Favorite

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

By Collin C.   Ehler E.   Waberzinek G.   Alsindi Z.   Davies P.   Powell K.   Notcutt W.   O'Leary C.   Ratcliffe S.   Nováková I.   Zapletalova O.   Piková J.   Ambler Z.  

Neurological Research, Vol. 32, Iss. 5, 2010-06 ,pp. : 451-459

Maney Publishing

Access to resources Recommend Favorite